David J Sullivan
Overview
Explore the profile of David J Sullivan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
2065
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Focosi D, Sullivan D, Franchini M
Expert Rev Anti Infect Ther
. 2025 Feb;
:1-8.
PMID: 40007187
Introduction: The success in the coronavirus infectious disease 2019 (COVID-19) pandemic containment largely originated from vaccine- and infection-elicited immunity, with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection only marginally...
2.
Kennedy G, Kennedy G, West R, Poti K, Bobb B, Ippolito M, et al.
bioRxiv
. 2025 Feb;
PMID: 39990335
Cethromycin combines a quinoline nucleus and a macrolide for broad spectrum antibacterial and antiprotozoan activity. Here we characterized the murine pharmacokinetics and lifecycle stage pharmacodynamics for the cethromycin base. Liver...
3.
Walker L, Bagonza V, Bobb B, Sullivan D
Int J Parasitol Drugs Drug Resist
. 2025 Jan;
27():100577.
PMID: 39746289
Fosmidomycin and clindamycin target the Plasmodium apicoplast. Combination clinical trials have produced mixed results with the primary problem being the recrudescent infection frequency by day 28. Given that antibiotic efficacy...
4.
Sayeed A, Atkinson R, Vekilov P, Rimer J, Sullivan D
Antimicrob Agents Chemother
. 2024 Dec;
69(1):e0120824.
PMID: 39665558
The antimalarial quinolines pyronaridine and chloroquine both inhibit hemozoin crystallization, predominately produced by intra-erythrocytic trophozoite stage parasites. Pyronaridine extends activity to ring-stage chloroquine-sensitive parasites, in contrast to chloroquine. Here, we...
5.
Yarava A, Marshall C, Reichert D, Ye A, Khanal P, Robbins S, et al.
J Clin Transl Sci
. 2024 Dec;
8(1):e200.
PMID: 39655012
Introduction: In response to the COVID-19 pandemic, we rapidly implemented a plasma coordination center, within two months, to support transfusion for two outpatient randomized controlled trials. The center design was...
6.
Dragotakes Q, Johnson P, Buras M, Carter R, Joyner M, Bloch E, et al.
Proc Natl Acad Sci U S A
. 2024 Oct;
121(41):e2414957121.
PMID: 39352932
In the Spring of 2020, the United States of America (USA) deployed COVID-19 convalescent plasma (CCP) to treat hospitalized patients. Over 500,000 patients were treated with CCP during the first...
7.
Wouters C, Sachithanandham J, Akin E, Pieterse L, Fall A, Truong T, et al.
Viruses
. 2024 Sep;
16(9).
PMID: 39339912
SARS-CoV-2 infection of immunocompromised individuals often leads to prolonged detection of viral RNA and infectious virus in nasal specimens, presumably due to the lack of induction of an appropriate adaptive...
8.
Franchini M, Cruciani M, Mengoli C, Casadevall A, Glingani C, Joyner M, et al.
Clin Microbiol Infect
. 2024 Jul;
30(12):1514-1522.
PMID: 39067517
Background: Plasma collected from recovered patients with COVID-19 (COVID-19 convalescent plasma [CCP]) was the first antibody-based therapy employed to fight the COVID-19 pandemic. While the therapeutic effect of early administration...
9.
Meschi S, Colavita F, Carletti F, Mazzotta V, Matusali G, Specchiarello E, et al.
Sci Rep
. 2024 Jun;
14(1):13487.
PMID: 38866796
Since spring 2022, the global epidemiology of the monkeypox virus (MPXV) has changed. The unprecedented increase of human clade II MPXV cases worldwide heightened concerns about this emerging zoonotic disease....
10.
Bloch E, Sullivan D, Casadevall A, Shoham S, Tobian A, Gebo K
mBio
. 2024 May;
15(6):e0110924.
PMID: 38780294
Infectious diseases are emerging and re-emerging far more frequently than many appreciate. In the past two decades alone, there have been numerous outbreaks (e.g., Ebola, chikungunya, Zika, and Mpox) and...